ECOR

+ Watchlist + Portfolio

electroCore, Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $10.81
52-Week Range: $4.41 – $10.93
Market Cap: $92.05M
P/E (TTM): —
EPS (TTM): -1.65
Dividend Yield: —

Advanced Metrics

Price/Book: —
PEG Ratio: —
Return on Equity: —
Return on Assets: -55.00%
Gross Margin: 87.06%
Operating Margin: -29.33%
Profit Margin: -39.96%
Current Ratio: 1.21
Debt/Equity: —
Total Debt: $9.56M
Free Cash Flow: $-4.68M
Revenue Growth: 28.00%
Earnings Growth: —
Enterprise Value: $96.98M

ECOR Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$8.59M	$16.03M	$25.18M	$32.03M
Cost of Revenue	$1.62M	$2.80M	$3.79M	$4.24M
Gross Profit	$6.98M	$13.23M	$21.40M	$27.79M
Research & Development	$5.52M	$5.32M	$2.36M	$2.73M
Selling, General & Admin	$24.33M	$27.17M	$31.20M	$38.21M
Operating Expenses	$29.85M	$32.49M	$33.56M	$40.94M
Operating Income	-$22.87M	-$19.27M	-$12.16M	-$13.15M
EBITDA	-$22.28M	-$18.24M	-$10.33M	-$11.70M
Pretax Income	-$22.59M	-$19.02M	-$11.98M	-$13.96M
Income Tax	-$431.00K	-$186.00K	-$93.00K	$3.00K
Net Income	-$22.16M	-$18.83M	-$11.89M	-$13.97M
Diluted EPS	-4.69	-3.42	-1.59	-1.65
Diluted Shares	4.73M	5.51M	7.48M	8.48M

ECOR Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$17.71M	$10.33M	$3.70M	$7.04M
Receivables	$401.00K	$717.00K	$1.37M	$1.03M
Inventory	$1.98M	$2.16M	$1.68M	$1.63M
Current Assets	$21.17M	$14.29M	$16.30M	$15.67M
Total Assets	$24.76M	$16.10M	$20.47M	$18.67M
Current Liabilities	$7.04M	$8.12M	$9.15M	$11.35M
Long-Term Debt	—	—	—	$6.61M
Total Debt	$699.00K	$626.00K	$4.14M	$9.40M
Total Liabilities	$7.67M	$8.66M	$12.93M	$20.38M
Retained Earnings	-$146.37M	-$165.20M	-$177.09M	-$191.06M
Shareholders' Equity	$17.09M	$7.44M	$7.54M	-$1.71M
Working Capital	$14.13M	$6.17M	$7.15M	$4.32M

ECOR Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$16.64M	-$14.67M	-$6.95M	-$8.19M
Capital Expenditure	—	-$206.00K	—	-$66.00K
Free Cash Flow	-$16.64M	-$14.87M	-$6.95M	-$8.25M
Depreciation & Amortisation	$596.00K	$1.02M	$1.26M	$1.68M
Stock-Based Compensation	$2.68M	$1.70M	$1.87M	$1.93M
Investing Cash Flow	$0.00	-$206.00K	-$8.52M	$3.88M
Financing Cash Flow	$0.00	$7.49M	$8.44M	$7.63M
Dividends Paid	$0.00	$0.00	—	—
Net Change in Cash	-$16.64M	-$7.39M	-$7.03M	$3.32M

ECOR Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$6.72M	$7.38M	$8.69M	$9.24M	$9.58M
Cost of Revenue	$1.01M	$939.00K	$1.22M	$1.07M	$1.22M
Gross Profit	$5.71M	$6.44M	$7.47M	$8.17M	$8.36M
Research & Development	$642.00K	$511.00K	$662.00K	$920.00K	$740.00K
Selling, General & Admin	$8.89M	$9.44M	$9.69M	$10.19M	$12.94M
Operating Expenses	$9.53M	$9.95M	$10.35M	$11.11M	$13.68M
Operating Income	-$3.82M	-$3.51M	-$2.88M	-$2.94M	-$5.32M
EBITDA	-$3.70M	-$3.35M	-$3.04M	-$1.49M	-$5.23M
Pretax Income	-$3.90M	-$3.67M	-$3.40M	-$2.98M	-$5.59M
Income Tax	-$48.00K	$0.00	$0.00	$51.00K	-$321.00K
Net Income	-$3.85M	-$3.67M	-$3.40M	-$3.04M	-$5.27M
Diluted EPS	-0.47	-0.44	-0.40	—	-0.59
Diluted Shares	8.29M	8.32M	8.45M	—	8.95M

ECOR Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$3.78M	$3.37M	$7.86M	$7.04M	$4.85M
Receivables	$1.46M	$813.00K	$1.48M	$1.03M	$872.00K
Inventory	$1.73M	$1.43M	$1.21M	$1.63M	$1.98M
Current Assets	$11.97M	$10.56M	$17.35M	$15.67M	$12.53M
Total Assets	$16.04M	$14.56M	$21.41M	$18.67M	$15.48M
Current Liabilities	$7.86M	$9.62M	$12.14M	$11.35M	$12.31M
Long-Term Debt	—	—	$6.53M	$6.61M	$6.44M
Total Debt	$4.18M	$4.23M	$10.81M	$9.40M	$9.48M
Total Liabilities	$11.68M	$13.45M	$22.48M	$20.38M	$21.17M
Retained Earnings	-$180.94M	-$184.62M	-$188.02M	-$191.06M	-$196.33M
Shareholders' Equity	$4.37M	$1.11M	-$1.07M	-$1.71M	-$5.69M
Working Capital	$4.12M	$939.00K	$5.21M	$4.32M	$213.00K
Net Debt	—	—	—	—	$1.83M

ECOR Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	-$4.36M	-$623.00K	-$1.67M	-$1.54M	-$3.01M
Capital Expenditure	-$37.00K	-$25.00K	-$4.00K	—	-$2.00K
Free Cash Flow	-$4.39M	-$648.00K	-$1.67M	-$1.54M	-$3.01M
Depreciation & Amortisation	$194.00K	$159.00K	$153.00K	$1.17M	$47.00K
Stock-Based Compensation	$540.00K	$505.00K	$415.00K	$470.00K	$1.04M
Investing Cash Flow	$4.50M	$185.00K	-$1.33M	$518.00K	$597.00K
Financing Cash Flow	$180.00K	$3.00K	$7.48M	-$40.00K	$230.00K
Net Change in Cash	$325.00K	-$435.00K	$4.49M	-$1.06M	-$2.18M

Market Snapshot

About

electroCore, Inc. is a commercial-stage bioelectronic medicine company developing non-invasive vagus nerve stimulation (nVNS) therapies. The company's gammaCore device delivers electrical stimulation through the skin to the vagus nerve in the neck, approved for treating cluster headache and migraine. electroCore's platform technology represents a drug-free approach to treating various conditions by modulating neural pathways. The company continues clinical development programs exploring additional therapeutic applications for its non-invasive neuromodulation technology.